These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 8722843)

  • 1. Role of azoles in antifungal therapy.
    Kauffman CA
    Clin Infect Dis; 1996 May; 22 Suppl 2():S148-53. PubMed ID: 8722843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral azole drugs as systemic antifungal therapy.
    Como JA; Dismukes WE
    N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Commonly used antifungal agents in the treatment of systemic mycoses].
    Berenguer Berenguer J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
    [No Abstract]   [Full Text] [Related]  

  • 4. Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
    Viviani MA
    Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azole drug resistance in yeasts.
    Johnson EM; Warnock DW
    J Antimicrob Chemother; 1995 Nov; 36(5):751-5. PubMed ID: 8626255
    [No Abstract]   [Full Text] [Related]  

  • 6. Fungal infection overview.
    Treat Rev; 1995 May; (no 18):10. PubMed ID: 11362589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal agents. Part II. The azoles.
    Terrell CL
    Mayo Clin Proc; 1999 Jan; 74(1):78-100. PubMed ID: 9987539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azoles and AIDS.
    Larsen RA
    J Infect Dis; 1990 Sep; 162(3):727-30. PubMed ID: 2167339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antifungal agent resistance of yeasts of clinical significance].
    Odds FC
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():56-7. PubMed ID: 9441307
    [No Abstract]   [Full Text] [Related]  

  • 10. Newer developments in therapy for endemic mycoses.
    Kauffman CA
    Clin Infect Dis; 1994 Aug; 19 Suppl 1():S28-32. PubMed ID: 7948568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Itraconazole: managing mycotic complications in immunocompromised patients.
    Graybill JR
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):58-63. PubMed ID: 9671333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endemic mycoses: a treatment update.
    Lortholary O; Denning DW; Dupont B
    J Antimicrob Chemother; 1999 Mar; 43(3):321-31. PubMed ID: 10223586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of azoles for systemic antifungal therapy.
    Kauffman CA; Carver PL
    Adv Pharmacol; 1997; 39():143-89. PubMed ID: 9160115
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Saag MS; Cloud GA; Graybill JR; Sobel JD; Tuazon CU; Johnson PC; Fessel WJ; Moskovitz BL; Wiesinger B; Cosmatos D; Riser L; Thomas C; Hafner R; Dismukes WE
    Clin Infect Dis; 1999 Feb; 28(2):291-6. PubMed ID: 10064246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
    van 't Wout JW; Kuijper EJ; Verweij PE; Kullberg BJ
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1679-84. PubMed ID: 15453120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group.
    Galgiani JN; Catanzaro A; Cloud GA; Johnson RH; Williams PL; Mirels LF; Nassar F; Lutz JE; Stevens DA; Sharkey PK; Singh VR; Larsen RA; Delgado KL; Flanigan C; Rinaldi MG
    Ann Intern Med; 2000 Nov; 133(9):676-86. PubMed ID: 11074900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment for HIV-related fungal infections.
    Hanna L
    BETA; 1995 Jun; ():10-7. PubMed ID: 11362539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
    Prentice AG; Glasmacher A; Djulbegovic B
    Br J Haematol; 2006 Mar; 132(5):656-8; author reply 658-9. PubMed ID: 16445845
    [No Abstract]   [Full Text] [Related]  

  • 19. Azole antifungal agents.
    Bodey GP
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for treatment of fungal infections.
    Med Lett Drugs Ther; 1992 Feb; 34(864):14-6. PubMed ID: 1310518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.